Charles River Laboratories Inte (CRL)
Tests drugs and develops lab animals for pharmaceutical and biotech companies before human trials.
$224.30-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+34.4%
The outlook
Charles River Laboratories is trading near the top of its 52-week range, well above both its 50- and 200-day moving averages. Analysts lean decidedly bullish with a "Buy" consensus, and their average price target sits about 3% above the current level. The stock shows solid upward momentum in its recent trend.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 15 analysts
Price trendAbove its 50- & 200-day averages
52-week range85% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 15 analysts$230.93average target+3.0% vs now
Now $224.30
Low $135.00High $265.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$238.85
52-wk low
$144.26
50-day avg
$197.92
200-day avg
$185.92
Trailing P/E
—